Use of standardized reverse transcription-polymerase chain reaction and the standardized expression measurement center in multiinstitutional trials to develop meaningful lung cancer classification based on molecular genetic criteria

Chest

Volumn 125, Issue 5 SUPPL., 2004, Pages 155S-156S

  Willey, James C ^a   Knight, Charles R ^a   Crawford, Erin L ^a   Olson, Dan E ^a   Hammersly, Jeffrey ^a   Yoon, Youngsook ^a   Sharief, Imran ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P21; TRANSCRIPTION FACTOR E2F1;

ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; COMPUTER PROGRAM; CONFERENCE PAPER; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; GENE EXPRESSION; GENE IDENTIFICATION; HEALTH PROGRAM; LUNG CARCINOMA; MEASUREMENT; MOLECULAR GENETICS; ONCOGENE MYC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD;

EID: 2442564294     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5_suppl.155S     Document Type: Conference Paper

References (0)